WASHINGTON, D. C. - Drug shortages during the coronavirus pandemic prompted U.S. Sen. Sherrod Brown to introduce legislation that would build a more resilient U.S. supply chain for generic medicines by creating a one-year, emergency supply of key drug ingredients and encouraging domestic companies to make them.

The “Promoting Readiness and Ensuring Proper Active Pharmaceutical Ingredient Reserves of Essential Medicines (PREPARE) Act of 2021? that Brown introduced with Republican Sen. Bill Cassidy of Louisiana would require the Secretary of Health and Human Services to maintain a list of essential generic medicines, and build out a domestic supply of the critical ingredients needed to manufacture them, Brown told reporters Wednesday.

Their bill would also establish a new federal entity to identify, purchase, track, transport, manage, store and convert an emergency supply of active pharmaceutical ingredients for essential generic medicines and designate an HHS official to oversee the job.

To Read The Full Article, Click Here.